heart failure

AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
Flag link:
Janssen taps wearable tech in Invokana heart failure trial
Janssen taps wearable tech in Invokana heart failure trial
Pharmaforum
JNJ
Janssen
Invokana
heart failure
wearables
real world evidence
clinial trials
Flag link:
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Flag link:
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Flag link:
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Flag link:
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
Fierce Pharma
AstraZeneca
Farxiga
EASD
heart failure
Flag link:
AstraZeneca diabetes drug granted fast track status for heart failure treatment
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Flag link:
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
Fierce Pharma
AstraZeneca
Farxiga
drug reps
heart failure
Flag link:
Heart failure results could unlock key market for Farxiga – AZ
Heart failure results could unlock key market for Farxiga – AZ
Pharmaforum
AstraZeneca
heart failure
diabetes
Farxiga
Flag link:
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
Flag link:
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
The Hill
FDA
heart failure
drug development
Flag link:
Novartis heart drug fails trial, curbing growth prospects
Novartis heart drug fails trial, curbing growth prospects
Yahoo/Reuters
Novartis
heart failure
Entresto
clinical trials
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
diabetes
heart disease
cardiometabolic health
heart failure
Flag link:
ED Drug Shows Promise in Sheep Heart Failure Study
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
heart failure
tadalafil
Pfizer
Viagra
Eli Lilly
Cialis
Flag link:
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Flag link:
Amgen, Servier heart failure drug clears trial hurdle
Amgen, Servier heart failure drug clears trial hurdle
PM Live
Amgen
Servier
heart failure
Omecamtiv Mecarbil
clinical trials
Flag link:
American College of Cardiology Conference Roundup - day 1
American College of Cardiology Conference Roundup - day 1
CP Wire
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
Flag link:

Pages